Private equity fundraising struggled in 2024, with total capital raised declining for the third consecutive year. Read more ...

A proposal backed by Gov. Bob Ferguson to increase student access to free meals served at public schools also appears dead, at least for now.

Markets worldwide defied expectations in 2024 led by the dominating performance of mega-cap technology stocks known as the ...

Bluebird Bio announced Friday it would sell itself and its portfolio of gene therapies to the investment firms Carlyle and SK ...

For the very first time, the storied Bemelmans Bar within The Carlyle, A Rosewood Hotel, has popped up outside of its Upper ...

The Pacers center had a big night against the Grizzlies and Carlisle had a message for the rest of the league.

Bluebird Bio will sell itself to private equity firms Carlyle and SK Capital for about $30 million, the company said Friday.

Cash-strapped gene-therapy company Bluebird bio agreed to be acquired by private-equity firms Carlyle Group and SK Capital ...

The pioneering gene therapy developer will be acquired by investment firms Carlyle Group and SK Capital for a fraction of ...

The Carlyle Group and SK Capital Partners have agreed to acquire bluebird bio, Inc, a Somerville, Massachusetts-based gene therapy firm, in a take-private deal. According to terms of the agreement, ...

There is a catch. If the private equity firms can boost sales of bluebird’s three gene therapies to $600 million—over any ...